Table 1: Baseline characteristics of the study subjects

MDD (n=25 eyes) Controls (n=25 eyes) P-value
Age (yrs) 57 + 13.73 56.28 + 6.21 0.41a
Female, n (%) 19 (76%) 17 (68%) 0.09b
Therapy, n (%)
Washout 5 (20%)
SSRI/SNRI monotherapy 12 (48%)
SSRI/SNRI + atypical antipsychotic 8 (32%)
MDD: Major Depressive Disorder; yrs: Years; SSRI: Serotonin reuptake inhibitor; SNRI: Serotonin-Norepinephrine reuptake inhibitor; Data are expressed as mean + standard deviation (SD); P-value less than 0.05 were considered statistically significant; aunpaired t test; bχ-square test;